Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients.
about
Incidence, risk factors and outcomes of de novo malignancies post liver transplantationThe conundrum of causality in tumor virology: the cases of KSHV and MCVDonor transmitted and de novo cancer after liver transplantation.De novo malignancy in organ transplant recipients in Taiwan: a nationwide cohort population studyMerkel cell carcinoma in immunosuppressed patients.What's new in clinical solid organ transplantation by 2013.Cancer Incidence among Heart, Kidney, and Liver Transplant Recipients in Taiwan.Post-transplant malignancy in liver transplantation: a single center experienceThe Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy.Cancer in the transplant recipient.De novo cancers following liver transplantation: a single center experience in China.Skin changes following organ transplantation: an interdisciplinary challenge.Nationwide population-based study reveals increased malignancy risk in taiwanese liver transplant recipients.Differences in long-term survival among liver transplant recipients and the general population: a population-based Nordic study.Posttransplant Lymphoproliferative Disorder: Otolaryngological Manifestations and Management.Cervical human papillomavirus infection in the early postoperative period after liver transplantation: Prevalence, risk factors, and concordance with anal infections.Iatrogenic immunosuppression and risk of non-Hodgkin lymphoma in solid organ transplantation: A population-based cohort study in Australia.Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis.Longitudinal dose and type of immunosuppression in a national cohort of Australian liver, heart, and lung transplant recipients, 1984-2006.De novo malignancy after lung transplantation in Japan.De novo malignant disease after liver transplantation? Risk and surveillance strategies.Decreasing incidence of cancer after liver transplantation-A Nordic population-based study over 3 decades.Posttransplant Lymphoproliferative Disorder After Clinical Islet Transplantation: Report of the First Two Cases.Effects of mTOR-Is on malignancy and survival following renal transplantation: A systematic review and meta-analysis of randomized trials with a minimum follow-up of 24 months.
P2860
Q26748580-2205A2B3-2B44-42F5-A3D1-2C7D458477E4Q26863112-4E1F8526-81CB-4477-8331-2F54AF33B9F5Q33661124-66059ED2-0C01-4ABA-A5F3-0A7728BFE8B2Q33829612-DFA661EF-B43E-4636-806B-49925F580BC7Q34309887-99FC6F26-B61D-4D66-A202-B37F74D17E56Q34761349-77C0368D-4F44-410A-99FC-BD6FF62BF19CQ36022600-588AC6E6-FB67-4447-B899-61EF37A0A0DCQ36154140-74E7838E-C93C-419C-8653-FEFE2E35291CQ36268539-DC231AA5-6BDE-4E06-A33B-84791D14F027Q36938488-FE8CAE5B-DB37-445B-9644-4DFD6A4B42FFQ37514160-699891E6-F184-4F5D-8A03-2058A2E31835Q37687958-3CF3691E-0217-48AE-A8FE-3CC4674542CEQ37696382-36775401-AEEB-4C9E-8197-67E36BA22838Q38418542-DA4DCE38-CEB8-47D8-B968-44650EB56C69Q38680172-35D0F87F-E889-47DF-8105-1AA080D23EBEQ39091662-EEFAF56D-C5A6-44E7-B4CB-1DD2A62EB5F7Q39803518-419C8352-4BE9-458D-82AD-752FC2340172Q40302905-2E2F5CD3-4ACC-4B7A-894D-D93FA79D9CB1Q40637683-538704A3-C379-4F4F-A505-3BEC4A788C7AQ40642407-B69E367D-A84F-478D-B191-0983D4FABB2AQ43857210-728A4E0D-4C1E-4786-86CB-8B84EAD6EE94Q47688116-B40D9EDD-99F2-4290-A46F-D44B27243AE1Q47799831-81B70FD2-6F66-4E92-82DB-E452996ED78EQ55265769-1C2116DB-AE7E-4FB8-96DE-28E6E3BBCF60
P2860
Comparison of de novo cancer incidence in Australian liver, heart and lung transplant recipients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Comparison of de novo cancer i ...... nd lung transplant recipients.
@en
Comparison of de novo cancer i ...... nd lung transplant recipients.
@nl
type
label
Comparison of de novo cancer i ...... nd lung transplant recipients.
@en
Comparison of de novo cancer i ...... nd lung transplant recipients.
@nl
prefLabel
Comparison of de novo cancer i ...... nd lung transplant recipients.
@en
Comparison of de novo cancer i ...... nd lung transplant recipients.
@nl
P2093
P2860
P1476
Comparison of de novo cancer i ...... and lung transplant recipients
@en
P2093
P2860
P304
P356
10.1111/J.1600-6143.2012.04302.X
P407
P577
2012-10-24T00:00:00Z